Bionexus Gene LabBGLC
13F holders, Q4 2025 (December 31)1holders −1
0new positions
1sold out
$3.95avg. 13F price*
At the end of Q4 2025, 1 institutions reported holding Bionexus Gene Lab Corp. (BGLC) in their 13F filings, down 1 from Q3 2025. 0 opened new positions and 1 sold out. The largest holder was DRW Securities, LLC ($189K).
- Company
- Bionexus Gene Lab Corp.
- CUSIP
- 090628306
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $42K |
All 13F filers, Q3 2025 → Q4 2025: 33,179 shares bought and 7,626 shares sold, net +25,553 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| DRW Securities, LLC | 0.01% | Add +226.5% | 47,830 | $189K |
"% of holder's portfolio" is BGLC's weight in each manager's 13F, not the share of Bionexus Gene Lab Corp. the manager owns.